Allergies News and Research

Latest Allergies News and Research

AIR2 trial: Alair BT System shows therapy benefits in adults with severe uncontrolled asthma

Five-year data from the Asthma Intervention Research 2 clinical trial presented today demonstrated that the Boston Scientific Corporation Alair Bronchial Thermoplasty System continues to show therapy benefits in adult patients with severe uncontrolled asthma.

22 May 2013

Study explores links between asthma, sleep quality and academic performance in urban schoolchildren

The negative effects of poorly controlled asthma symptoms on sleep quality and academic performance in urban schoolchildren has been confirmed in a new study.

22 May 2013

Early-life exposure to traffic-related air pollution associated with higher hyperactivity

Early-life exposure to traffic-related air pollution was significantly associated with higher hyperactivity scores at age 7, according to new research from the University of Cincinnati (UC) and Cincinnati Children's Hospital Medical Center.

21 May 2013

Nighttime intensivists have no effect on ICU length of stay, find researchers

With little evidence to guide them, many hospital intensive care units have been employing critical care physicians at night with the notion it would improve patients' outcomes. However, new results from a one-year randomized trial from researchers at Penn Medicine involving nearly 1,600 patients admitted to the Hospital of the University Pennsylvania Medical ICU suggest otherwise: Having a nighttime intensivist had no clear benefit on length of stay or mortality for these patients, not even patients admitted at night or those with the most critical illnesses at the time of admission.

21 May 2013

Parents need to protect children from allergen exposure, says Hope Paige CEO

A report released earlier this month by the Centers for Disease Control and Prevention calls allergy rates among U.S. children an "epidemic."

18 May 2013

Sorrento Therapeutics' anti-MRSA program gets NIAID support

Sorrento Therapeutics, Inc. announced today that its Fast-Track Advanced Technology Small Business Technology Transfer Research grant (#1R42AI098182-02) from the National Institute of Allergy and Infectious Diseases, a division of the National Institutes of Health, supporting the development of novel human antibody therapeutics to combat Staphylococcus aureus (S. aureus or Staph) infections, including methicillin-resistant S. aureus, was renewed for the second year of a two year Phase I grant award.

18 May 2013

Simponi injection gets FDA approval to treat adults with ulcerative colitis

The U.S. Food and Drug Administration today approved a new use for Simponi (golimumab) injection to treat adults with moderate to severe ulcerative colitis.

16 May 2013

ALK, AAFA partner to create unique online resource for people living with allergies

In the latest effort to educate and enable the allergic patient to take control of their disease, ALK, a leading company focusing on allergy treatment, and the Asthma and Allergy Foundation of America have partnered to create a unique online resource for patients.

15 May 2013

A growing number of patients learn of allergies only after surgery is done

Imagine what Paula Spurlock must have been going through. Shortly after having a hip replaced in 2011, the trouble started. "I had horrible itching, really bad migraines and intense pain throughout my body," she said. "I couldn't take it. Every single thing in me itched."

15 May 2013

UIC's Center for Clinical and Translational Science selects six research projects for new pilot grants

The University of Illinois at Chicago's Center for Clinical and Translational Science has selected six research projects to receive pilot grants in 2013.

15 May 2013

Better understanding of cells' development has implications in study of inflammatory diseases

Labs around the world, and a core group at Penn, have been studying recently described populations of immune cells called innate lymphoid cells. Some researchers liken them to foot soldiers that protect boundary tissues such as the skin, the lining of the lung, and the lining of the gut from microbial onslaught. They also have shown they play a role in inflammatory disease, when the body's immune system is too active.

15 May 2013

COPD patients with allergic phenotype have increased risk of lower respiratory symptoms, exacerbations

Patients with chronic obstructive pulmonary disease (COPD) who also have allergic disease have higher levels of respiratory symptoms and are at higher risk for COPD exacerbations, according to a new study from researchers at Johns Hopkins University in Baltimore.

10 May 2013

Study identifies national variations in using antibiotics to treat ARS

Antibiotics for acute rhinosinusitis are prescribed frequently- especially for younger adult patients and in primary care settings-despite recent consensus guidelines that discourage antibiotic use in mild cases, according to a study in the May 2013 issue of Otolaryngology-Head and Neck Surgery.

10 May 2013

Synageva BioPharma reports study results of sebelipase alfa in adults with late onset LAL Deficiency

Synageva BioPharma Corp., a biopharmaceutical company developing therapeutic products for rare diseases, today reported 12-month results from an ongoing extension study with sebelipase alfa in adults with late onset Lysosomal Acid Lipase Deficiency.

9 May 2013

Viewpoints: Capitol Hill antics on budget; A mom's concern about Plan B decision

Republicans, after berating Democrats for enacting Obamacare and other bills behind closed doors with extra-parliamentary procedures, are insisting that any talks with Democrats be behind closed doors with extra-parliamentary procedures.

9 May 2013

Nearly 5 million asthmatics with ABPA could benefit from antifungal treatment, say researchers

An estimated 4,837,000 asthmatics with allergic bronchopulmonary aspergillosis (ABPA) could benefit substantially from antifungal treatment, say researchers from the University of Toronto and Manchester University.

9 May 2013

Phase 1b clinical study data of EBI-005 for treatment of dry eye disease presented at ARVO meeting

Eleven Biotherapeutics, a biopharmaceutical company designing and engineering novel and differentiated protein-based biotherapeutics for ocular diseases, announced today the presentation of data for EBI-005, the first IL-1 (Interleukin-1) signaling inhibitor designed for topical ocular administration, at the Association for Research in Vision and Ophthalmology 2013 Annual Meeting in Seattle, Washington.

9 May 2013

FDA accepts Merck's BLA for investigational ragweed pollen sublingual allergy immunotherapy tablet

Merck, known as MSD outside the United States and Canada, today announced that the Biologics License Application for its investigational ragweed pollen (Ambrosia artemisiifolia) sublingual allergy immunotherapy tablet has been accepted for review by the U.S. Food and Drug Administration.

9 May 2013

Peripheral neuropathic pain patch treatments: an interview with Anne Hodgkins, Astellas Pharma

Peripheral neuropathic pain is caused by lesion or disease to the peripheral somatosensory nervous system. Nerve damage that can lead to peripheral neuropathic pain can happen as a result of a range of different diseases, medications or traumatic injuries.

8 May 2013

Study investigates use of sublingual immunotherapy against ragweed allergy

An international team of researchers, led by physician-scientists at Johns Hopkins, reports that a once-daily tablet containing a high dose of a key ragweed pollen protein effectively blocks the runny noses, sneezes, nasal congestion and itchy eyes experienced by ragweed allergy sufferers.

8 May 2013

Allergies News and Research

Latest Allergies News and Research

AIR2 trial: Alair BT System shows therapy benefits in adults with severe uncontrolled asthma

Study explores links between asthma, sleep quality and academic performance in urban schoolchildren

Early-life exposure to traffic-related air pollution associated with higher hyperactivity

Nighttime intensivists have no effect on ICU length of stay, find researchers

Parents need to protect children from allergen exposure, says Hope Paige CEO

Sorrento Therapeutics' anti-MRSA program gets NIAID support

Simponi injection gets FDA approval to treat adults with ulcerative colitis

ALK, AAFA partner to create unique online resource for people living with allergies

A growing number of patients learn of allergies only after surgery is done

UIC's Center for Clinical and Translational Science selects six research projects for new pilot grants

Better understanding of cells' development has implications in study of inflammatory diseases

COPD patients with allergic phenotype have increased risk of lower respiratory symptoms, exacerbations

Study identifies national variations in using antibiotics to treat ARS

Synageva BioPharma reports study results of sebelipase alfa in adults with late onset LAL Deficiency

Viewpoints: Capitol Hill antics on budget; A mom's concern about Plan B decision

Nearly 5 million asthmatics with ABPA could benefit from antifungal treatment, say researchers

Phase 1b clinical study data of EBI-005 for treatment of dry eye disease presented at ARVO meeting

FDA accepts Merck's BLA for investigational ragweed pollen sublingual allergy immunotherapy tablet

Peripheral neuropathic pain patch treatments: an interview with Anne Hodgkins, Astellas Pharma

Study investigates use of sublingual immunotherapy against ragweed allergy

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Allergies News and Research

Latest Allergies News and Research

Small solutions for big problems in drug discovery and delivery

Professor Nancy Ip: Pioneering New Paths in Neurodegenerative Therapy

Utilizing process Raman in optimizing cultivated meat production

Newsletters you may be interested in